Armando Anido

Affiliations

  • at Scynexis Inc (SCYX), 2024-06-21
  • Chairman & Chief Exec. Officer at Zynerba Pharmaceuticals Inc. (ZYNE), 2023-10-11
  • Director at Aviragen Therapeutics Inc. (AVIR), 2017-05-22
  • Chief Executive Officer at Nupathe Inc. (PATH), 2014-02-25
  • Director at Adolor Corp (ADLR), 2011-12-08
  • Ceo & President at Auxilium Pharmaceuticals Inc (AUXL), 2011-10-12
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SCYX $6.25 5,000 $31,250.00 5,000 2020-12-21 Filing
ZYNE $5.96 15,000 $89,422.50 352,512 2018-08-06 Filing
ZYNE $19.57 1,500 $29,355.00 337,512 2017-05-15 Filing
ZYNE $19.76 3,500 $69,160.00 336,012 2017-05-12 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ZYNE $1.33 17,830 $23,637.23 936,722 2023-09-13 Filing
ZYNE $0.60 35,453 $21,193.80 576,235 2023-01-23 Filing
ZYNE $1.10 11,899 $13,088.90 611,688 2022-07-19 Filing
AUXL $14.23 5,275 $75,045.84 13,653 2011-10-07 Filing
AUXL $20.30 5,275 $107,100.96 13,653 2011-07-08 Filing